PTGX
#1016
Protagonist Therapeutics, Inc. - Common Stock
130.8 5 USD
+0.01%
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
Range Annuel
Changement quotidien
+0.74%
Changement Mensuel
+18.95%
Evolution sur 6 mois
+54.67%
Changement Annuel
+74.16%
Clôture Précédente
129.8 9
Open
129.9 5
Low
129.8 5
High
130.9 2
Volume
62
Financials
- Market Capitalization 8.42 B
- Employee 131
- Founded 2006
- CEO N/A
- Website www.protagonist-inc.com
- Headquarter Delaware, United States
- FIGI BBG002B63KM7
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-42.6
ratio cours/chiffre d'affaires
120.66
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 1008 |  TGTX TG Therapeutics, Inc. - Common Stock | 55.28 USD | +0.49% | -4.13% | +12.82% | +41.78% | 8.46 B USD | ||
| 1010 |  SYRE Spyre Therapeutics, Inc. - Common Stock | 101.51 USD | +8.30% | +8.68% | +24.45% | +324.55% | 8.82 B USD | ||
| 1020 |  APGE Apogee Therapeutics, Inc. - Common Stock | 134.12 USD | +0.22% | +0.52% | +49.59% | +150.27% | 8.30 B USD | ||
| 1021 |  IBRX ImmunityBio, Inc. - Common Stock | 7.97 USD | +2.31% | -6.89% | +9.93% | +172.95% | 8.35 B USD |